Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

Fungal infections caused by multi-drug resistant (MDR) pathogens pose a growing threat to human health. The identification of new and safe antifungals with novel modes of action is now vital.

Only four new antifungal drugs were approved over the last decade. The WHO urges for safer treatments and improved diagnostics, especially in low and middle-income countries, to address this ...

“Not only is the pipeline of new antifungal drugs and diagnostics insufficient, there is a void in fungal testing in low- and middle-income countries, even in district hospitals. This diagnostic ...

New Delhi: One of the most painful memories of the Covid-19 pandemic was families of patients suffering from a serious fungal infection called mucormycosis struggling to find drugs to treat the ...

This microscope photo provided by the Centers for Disease Control and Prevention shows a Fusarium sp. fungal organism in 1972. (Lucille K. Georg / ASSOCIATED PRESS) When most people think of ...

4. Antifungal Drugs Antifungal medications are used to treat fungal infections, such as athlete's foot and jock itch. They are available in topical, oral, and injectable forms. Certain antifungals ...

Fungal infections (mycoses) are a growing public health concern in India, affecting various body parts and posing risks of drug resistance if not managed properly, especially in vulnerable ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.